ProPhase Labs, Inc. (NASDAQ:PRPH – Get Free Report)’s stock price crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.08 and traded as low as $0.0090. ProPhase Labs shares last traded at $0.0106, with a volume of 718,539 shares trading hands.
ProPhase Labs Stock Performance
The company has a market capitalization of $226,500.00, a P/E ratio of -0.01 and a beta of 0.06. The company has a current ratio of 0.14, a quick ratio of 0.14 and a debt-to-equity ratio of 0.14. The company’s fifty day moving average is $0.04 and its 200 day moving average is $0.08.
About ProPhase Labs
ProPhase Labs, Inc is a diversified health and wellness company focused on diagnostics, genomics, consumer healthcare products and related biopharmaceutical opportunities. The company operates through businesses that develop and commercialize products and services intended to support disease detection, personalized health information and consumer wellness.
Its consumer healthcare operations include Cold-EEZE zinc-based products, which are marketed in forms such as lozenges and oral sprays for common-cold symptom support.
Featured Stories
- Five stocks we like better than ProPhase Labs
- Chips to Bots: Qualcomm’s Agentic AI Breakout
- Ciena Fell 40%—Now One Analyst Sees 50% Upside
- Energy Transfer Taps the AI Power Boom
- Viking’s Obesity Edge May Be Staying Power, Not Weight Loss
Receive News & Ratings for ProPhase Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProPhase Labs and related companies with MarketBeat.com's FREE daily email newsletter.
